All Posts
Expert Consensus | Imaging standardization in metastatic colorectal cancer.
26 Oct, 2022 | 14:36h | UTC
Optimizing medication use in older adults with rheumatic diseases: deprescribing as an approach when less may be more.
26 Oct, 2022 | 14:33h | UTCRelated:
Antihypertensive Deprescribing in Older Adults: a Practical Guide – Current Hypertension Reports
Deprescribing in Palliative Cancer Care – Life
Less is More: Deprescribing Medications in Older Adults with Kidney Disease: A Review – Kidney360
Polypharmacy Management in Older Patients – Mayo Clinic Proceedings
Eliminating Medication Overload: A National Action Plan – Lown Institute
Common ED Medication Errors: Polypharmacy – emDocs
Current and future perspectives on the management of polypharmacy – BMC Family Practice
Polypharmacy—an Upward Trend with Unpredictable Effects – Deutsches Ärzteblatt international
Clinical Consequences of Polypharmacy in Elderly – Expert Opinion on Drug Safety
RCT | Intraoperative electrocorticography using high-frequency oscillations or spikes to tailor epilepsy surgery.
26 Oct, 2022 | 14:34h | UTC
Review | Smartphone apps in stroke management.
26 Oct, 2022 | 14:31h | UTCSmartphone App in Stroke Management: A Narrative Updated Review – Journal of Stroke
Commentary: Stroke Management: There’s an App for That – Medscape (free registration required)
M-A | Age, sex, race, BMI, and duration of type 2 DM differences in cardiovascular outcomes with glucose lowering drugs.
26 Oct, 2022 | 14:32h | UTCCommentary: Meta-analysis may guide optimal type 2 diabetes glucose-lowering agent for MACE protection – medwire News
The bleeding cervical cancer patient: systematic approach and management.
26 Oct, 2022 | 14:30h | UTCThe Bleeding Cervical Cancer Patient: Systematic Approach and Management – emDocs
M-A of RCT | Sleep deprivation is not effective as a treatment for major depressive episodes.
26 Oct, 2022 | 14:29h | UTC
M-A | Non-affective psychotic disorders and risk of dementia.
26 Oct, 2022 | 14:30h | UTCCommentaries:
Psychotic Disorders May Raise Risk for Later Dementia – HealthDay
Single-arm P2 study | Toxic effects of stereotactic ablative radiotherapy for up to 5 oligometastases in patients with cancer.
26 Oct, 2022 | 14:28h | UTCTreatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer: Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical Trial – JAMA Oncology (link to abstract – $ for full-text)
Commentary on Twitter
Population-based phase 2 non-randomized trial of 381 pts w/oligometastatic or oligoprogressive disease & treated w/stereotactic ablative body radiotherapy (SABR) found rates of grade 2, 3,4, & 5 toxicities of 14.2%, 4.2%, 0%, & 0.3%, respectively. https://t.co/dDpdOEvNzk #RadOnc
— JAMA Oncology (@JAMAOnc) September 29, 2022
New horizons in Type 2 myocardial infarction: pathogenesis, assessment and management of an emerging geriatric disease.
26 Oct, 2022 | 14:27h | UTC
M-A | Non-pharmacologic and pharmacologic treatments for anxiety in long-term care.
26 Oct, 2022 | 14:26h | UTC
Phase 2 RCT | Immunoglobulin has no corticosteroid-sparing effects in Myasthenia Gravis.
26 Oct, 2022 | 14:25h | UTC
Differentiating multiple sclerosis from AQP4-neuromyelitis optica spectrum disorder and MOG-antibody disease with imaging.
26 Oct, 2022 | 14:24h | UTC
Commentary on Twitter
Published online: Cortese @RosaCortese5 and colleagues assessed whether imaging characteristics typical of multiple sclerosis (#MS) discriminate relapsing remitting MS from AQP4-NMOSD and #MOGAD, alone and in combination. Learn more: https://t.co/AWYoEZQDP9 #NeuroTwitter pic.twitter.com/3Pytn45uLx
— Neurology Journal (@GreenJournal) October 12, 2022
RCT | In critically ill patients receiving MV, there was no difference in outcomes between different O2 saturation targets.
25 Oct, 2022 | 13:23h | UTCOxygen-Saturation Targets for Critically Ill Adults Receiving Mechanical Ventilation – New England Journal of Medicine (link to abstract – $ for full-text)
Related:
Oxygen targets – Intensive Care Medicine (if the link is paywalled, try this one)
Commentary on Twitter
In this trial involving patients receiving mechanical ventilation, randomly assigned low, intermediate, or high oxygenation targets did not alter the number of ventilator-free days. @CritCareReviews https://t.co/UUxrEPRxs6 pic.twitter.com/ueUSX8ZmHG
— NEJM (@NEJM) October 24, 2022
Recommendations for laboratory testing of patients with acute myeloid leukemia.
25 Oct, 2022 | 13:21h | UTC
Diaphragmatic function in cardiovascular disease: JACC review topic of the week.
25 Oct, 2022 | 13:22h | UTC
Guideline | Reporting of surgically removed lymph nodes for breast tumors.
25 Oct, 2022 | 13:20h | UTC
ESGE Position Statement | Expected value of artificial intelligence in gastrointestinal endoscopy.
25 Oct, 2022 | 13:20h | UTC
RCT | Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis.
25 Oct, 2022 | 13:19h | UTCCommentary: Successful retreatment of axSpA flare feasible following ixekizumab withdrawal – medwire News
RCT | Effect of a novel brief motivational intervention for alcohol-intoxicated young adults in the emergency department.
25 Oct, 2022 | 13:18h | UTCSee also: Visual Abstract
Post-trial follow-up | IV calcium does not improve long-term outcomes in patients with out-of-hospital cardiac arrest.
25 Oct, 2022 | 13:17h | UTCOriginal Study: RCT: Intravenous or intraosseous calcium does not improve the return of spontaneous circulation in adults with out-of-hospital cardiac arrest.
Commentary on Twitter
From the latest issue of @ResusJournal Effect of calcium vs. placebo on long-term outcomes in patients with out-of-hospital cardiac arrest https://t.co/fSCr9DebS7 pic.twitter.com/rRw28GwP5Q
— Emergency Medicine (@ELS_Emerg_Med) September 2, 2022
Post-hoc analysis | Two-year visual field outcomes of the Treatment for Advanced Glaucoma Study (TAGS).
25 Oct, 2022 | 13:15h | UTCOriginal study and commentary: Study Commentary | Advanced glaucoma: surgery lowers pressure in the eye more effectively than eye drops.
Systematic Review | Point-of-care ultrasound in dyspnea, nontraumatic hypotension, and shock.
25 Oct, 2022 | 13:16h | UTC
Post-trial follow-up | Long-term treatment with Ponesimod in relapsing-remitting multiple sclerosis.
25 Oct, 2022 | 13:14h | UTCCommentary: Optimal Dose of Ponesimod for Control of Relapsing-Remitting Multiple Sclerosis – Neurology Advisor
Original Study: Oral ponesimod in relapsing–remitting multiple sclerosis: a randomised phase II trial – Journal of Neurology, Neurosurgery & Psychiatry
RCT | Transcutaneous Electrical Acustimulation (TEA) vs. sham-TEA for irritable bowel syndrome with constipation.
25 Oct, 2022 | 13:12h | UTC


